Monoclonal antibodies against recombinant-MAGE-1 protein identify a cross-reacting 72-kDa antigen which is co-expressed with MAGE-1 protein in melanoma cells

International Journal of Cancer

Volumn 67, Issue 3, 1996, Pages 417-422

  Carrel, Stefan ^a   Schreyer, Magali ^a   Spagnoli, Giulio ^b   Cerottini, Jean Charles ^a   Rimoldi, Donata ^a,c  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A1 ANTIGEN; HLA C ANTIGEN; MONOCLONAL ANTIBODY;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MELANOMA; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN PROTEIN INTERACTION; SKIN BIOPSY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; AZACITIDINE; CROSS REACTIONS; IMMUNOHISTOCHEMISTRY; MELANOMA; MICE; MICE, INBRED BALB C; NEOPLASM PROTEINS; RECOMBINANT PROTEINS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0029812081     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960729)67:3<417::AID-IJC17>3.0.CO;2-4     Document Type: Article

References (22)

1. BIRD, A., The essentials of DNA methylation. Cell, 70, 5-8 (1992).
2. BOON, T., Tumor antigens recognized by cytolytic T lymphocytes: present perspectives for specific immunotherapy. Int. J. Cancer, 54, 177-180 (1993).
3. BRASSEUR, F., MARCHAND, M., VANWIJCK, R., HERIN, M., LETHE, B., CHOMEZ, P. and BOON, T., Human gene MAGE-1, which codes for a tumor-rejection antigen, is expressed by some breast tumors. Int. J. Cancer, 52, 839-841 (1992).
4. BRASSEUR, F., and 27 others, Expression of MAGE genes in primary and metastatic cutaneous melanoma. Int. J. Cancer, 63, 375-380 (1995).
5. CARREL, S., ACCOLLA, R.S., CARMAGNOLA, A.L. and MACH, J.-P., Common human melanoma-associated antigen(s) detected by monoclonal antibodies. Cancer Res., 40, 2523-2528 (1980).
6. CHEN, Y.-T., STOCKERT, E., CHEN, Y., GARIN-CHESA, P., RETTIG, W.J., VAN DER BRUGGEN, P., BOON, T. and OLD, L.J., Identification of the MAGE-1 gene product by monoclonal and polyclonal antibodies. Proc. nat. Acad. Sci. (Wash.), 91, 1004-1008 (1994).
7. DE PLAEN, E., ARDEN, K., TRAVERSARI, C., GAFORIO, J.J., SZIKORA, J.-P., DE SMET, C., BRASSEUR, F., VAN DER BRUGGEN, P., LETHE, B., CHOMEZ, P., DE BACKER, O., CAVENEE, W. and BOON, T., Structure, chromosomal localization and expression of 12 genes of the MAGE family. Immunogenetics, 40, 360-369 (1994).
8. INOUE, H., LI, J., HONDA, M., NAKASHIMA, H., SHIBUTA, K., ARINAGA, S., UEO, H., MORI, M. and AKIYOSHI, T., MAGE-1-mRNA expression in gastric carcinoma. Int. J. Cancer, 64, 76-77 (1995).
9. MACH, J.-P. and PUSZTASZERI, G., Carcinoembryonic antigen (CEA): demonstration of partial identity between CEA and a normal glycoprotein. Immunochemistry, 9, 1031-1034 (1972).
10. MUSCATELLI, F., WALKER, A.P., DE PLAEN, E., STAFFORD, A.N. and MONACO, A.P., Isolation and characterization of a MAGE gene family in the Xp21.3 region. Proc. nat. Acad. Sci. (Wash.), 92, 4987-4991 (1995).
11. OAKS, M.K., HANSON, J.P. and O'MALLEY, D.P., Molecular cytogenetic mapping of the human melanoma antigen (MAGE) gene family to chromosome region Xq27-qter: implications for MAGE immunotherapy. Cancer Res., 54, 1627-1629 (1994).
12. PATARD, J.-J., BRASSEUR, F., GIL-DIEZ, S., RADVANYI, F., MARCHAND, M., FRANÇOIS, P., ABI-AAD, A., VAN CANGH, P., ABBOU, C.C., CHOPIN, D. and BOON, T., Expression of MAGE gene in transitional-cell carcinomas of the urinary bladder. Int. J. Cancer, 64, 60-64 (1995).
13. RIMOLDI, D., ROMERO, P. and CARREL, S., The human melanoma-antigen-encoding gene, MAGE-1, is expressed by other tumour cells of neuroectodermal origin such as gliobastomas and neuroblastomas. Int. J. Cancer, 54, 527-528 (1993).
14. RUSSO, V., TRAVERSARI, C., VERRECCHIA, A., MOTTOLESE, M., NATALI, P.G. and BORDIGNON, C., Expression of the MAGE gene family in primary and metastatic human breast cancer: implications for tumor-antigen-specific immunotherapy. Int. J. Cancer, 64, 216-221 (1995).
15. SCHULTZ-THATER, E., JURETIC, A., DELLABONA, P., LÜSCHER, U., SIEGRIST, W., HARDER, F., HERBERER, M., ZUBER, M. and SPAGNOLI, G.C., MAGE-1 gene product is a cytoplasmic protein. Int. J. Cancer, 59, 435-439 (1994).
16. THOMPSON, J.A., PANDE, H., PAXTON, R.J., SHIVELY, L., PADMA, A., SIMMER, R.L., TODD, C.W., RIGGS, A.D. and SHIVELY, J.E., Molecular cloning of a gene belonging to the carcinoembryonic antigen gene family and discussion of a domain model. Proc. nat. Acad. Sci. (Wash.), 84, 2965-2969 (1987).
17. TRAVERSARI, C., VAN DER BRUGGEN, P., LUESCHER, I.F., LUROUIN, C., CHOMEZ. P., VAN PEL, A., DE PLAEN, E., AMAR-COSTESEC, A. and BOON, T., A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J. exp. Med., 176, 1453-1457 (1992).
18. VAN DER BRUGGEN, P., SZIKORA, J.-P., BOEL, P., WILDMANN, C., SOMVILLE, M., SENSI, M. and BOON, T., Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw1601. Europ. J. Immunol., 24, 2134-2140 (1994).
19. VAN DER BRUGGEN, P., TRAVERSARI, C., CHOMEZ, P., LURQUIN, C., DE PLAEN, E., VAN DEN EYNDE, B., KNUTH, A. and BOON, T., A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science, 254, 1643-1647 (1991).
20. VAN PEL, A., VAN DER BRUGGEN, P., COULIE, P.G., BRICHARD, V.G., LETHE, B., VAN DEN EYNDE, B., UYTTENHOVE, C., RENAULD, J.C. and BOON, T., Genes coding for tumor antigens recognized by cytolytic T lymphocytes. Immunol. Rev., 145, 229-250 (1995).
21. WEYNANTS, P., LETHE, B., BRASSEUR, F., MARCHAND, M. and BOON, T., Expression of MAGE genes by non-small-cell lung carcinoma. Int. J. Cancer, 56, 826-829 (1994).
22. WEBER, J., SALGALLER, M., SAMID, D., JOHNSON, B., HERLYN, M., LASSAM, N., TREISMAN, J. and ROSENBERG, S.A., Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-Aza-2′-deoxycytidine. Cancer Res., 54, 1766-1771 (1994).